UNSPSC 51294902: Aceprometazine

This classification denotes an antidepressant agent with the molecular formula C19H22N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 984N9YTM4Y, chemically known as ketone, 10-(2-(dimethylamino)propyl)phenothiazin-2-yl methyl but generally known as aceprometazine, which bears US NIH Compound Identifier 26035. European Medicines Agency schedules Aceprometazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05214MIG. The term ACEPROMETAZINE is an International Non-Proprietary Name.

UNSPSC 51294902 Aceprometazine is a Commodity code that maps to pharmaceutical supply procurement, though recent state and local opportunities tagged under this code reflect a broader scope: naloxone and drug deactivation systems for community health, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals and over-the-counter products distributed through authorized wholesalers. State and local buyers under this family include county health departments, state health and human services agencies, and multistate cooperative purchasing alliances. Seminole County, Florida procures naloxone and safe drug deactivation systems through competitive bidding to support community health initiatives, while the Texas Health and Human Services Commission has issued a Request for Information to evaluate direct-to-manufacturer prescription capabilities for its pharmacy benefit program. The Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration's Office of State Procurement, solicits manufacturers of generic pharmaceuticals and OTC products for distribution across participating state and local government facilities including Oregon.

Recent activity spans Florida, Texas, and the upper Midwest. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for direct-to-manufacturer prescription programs, functioning as exploratory market research ahead of a formal RFP. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products, with responses due March 26, 2026 and contract awards effective July 1, 2026; vendors must work through authorized wholesalers AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC, maintain at least $5,000,000 in commercial general liability coverage, and comply with cGMP and Drug Supply Chain Security Act requirements. Pricing evaluation across the MMCAP procurement weights price competitiveness at 75 percent, with a 3 percent administrative fee applied to all purchases.